SLC22A23-C6ORF145 Fusion FISH Probe
The SLC22A23-C6ORF145 Fusion FISH Probe is used to confirm a fusion of the SLC22A23 and C6ORF145 genes. The fusion of the SLC22A23 and C6ORF145 genes has been associated with Stomach Adenocarcinoma, and Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC22A23-C6ORF145-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC22A23-C6ORF145-20-AQAQ | 20 (40 μL) | 200 μL |
|
SLC22A23 Gene Summary
SLC22A23 belongs to a large family of transmembrane proteins that function as uniporters, symporters, and antiporters to transport organic ions across cell membranes (Jacobsson et al., 2007 [PubMed 17714910]).[supplied by OMIM, Mar 2008]
Gene Name: Solute Carrier Family 22 Member 23
Chromosome: CHR6: 3269206 -3456793
Locus: 6p25.2
Gene Diseases
The SLC22A23 C6ORF145 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|